Your Article Summary
Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With Metformin
Archives of Internal Medicine, 10/14/08
Bays HE et al. - Colesevelam improves glycemic and lipid parameters in patients with T2DM inadequately controlled with metformin-based therapy.
Related Articles
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 100%
Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes
Hormone and Metabolic Research, 11/02/09
Relevance Score: 100%
Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Current Medical Research and Opinion, 10/22/09
Relevance Score: 100%
Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity
Current Medical Research and Opinion, 10/19/09
Relevance Score: 100%
Beyond Glycemic Control: Treating the Entire Type 2 Diabetes Disorder
Postgraduate Medicine, 10/05/09
Relevance Score: 100%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid
Journal of Allergy and Clinical Immunology, 12/08/09
Effects of budesonide and formoterol on allergen-induced airway responses, inflammation, and airway remodeling in asthma
Journal of Allergy and Clinical Immunology, 12/08/09
In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii
The Journal of Antibiotics, 12/08/09

See Latest Articles